BioCentury | May 28, 2005
Financial News

ProMetic proposes follow-on

ProMetic (TSE:PLI.SV) proposed to raise C$10-C$15 million (US$7.9-US$11.8 million) in a follow-on underwritten by Paradigm Capital; Sprott Securities; First Associates Investment; and Octagon Capital. ProMetic's PBI-1402 , a chemoprotective activator of neutrophils, will begin a Phase...
BioCentury | Dec 15, 2003
Financial News

YM BioSciences raises C$19.1M

...SDS Merchant Funds; OrbiMed; SCO Capital; Xmark; ProMed Partners; and Vertical Ventures. SCO Securities and First Associates Investments...
BioCentury | Feb 26, 2001
Finance

Ebb & Flow

...The IPO was underwritten by Acumen Capital Finance Partners; Raymond James; Dlouhy Merchant Group; and First Associates Investments...
BioCentury | Feb 26, 2001
Finance

Ebb & Flow

...The IPO was underwritten by Acumen Capital Finance Partners; Raymond James; Dlouhy Merchant Group; and First Associates Investments...
BioCentury | Feb 21, 2001
Financial News

Cytovax prices IPO

...250,005-share overallotment, was underwritten by Acumen Capital Finance Partners; Raymond James; Dlouhy Merchant Group; and First Associates Investments. BC...
Items per page:
1 - 5 of 5
BioCentury | May 28, 2005
Financial News

ProMetic proposes follow-on

ProMetic (TSE:PLI.SV) proposed to raise C$10-C$15 million (US$7.9-US$11.8 million) in a follow-on underwritten by Paradigm Capital; Sprott Securities; First Associates Investment; and Octagon Capital. ProMetic's PBI-1402 , a chemoprotective activator of neutrophils, will begin a Phase...
BioCentury | Dec 15, 2003
Financial News

YM BioSciences raises C$19.1M

...SDS Merchant Funds; OrbiMed; SCO Capital; Xmark; ProMed Partners; and Vertical Ventures. SCO Securities and First Associates Investments...
BioCentury | Feb 26, 2001
Finance

Ebb & Flow

...The IPO was underwritten by Acumen Capital Finance Partners; Raymond James; Dlouhy Merchant Group; and First Associates Investments...
BioCentury | Feb 26, 2001
Finance

Ebb & Flow

...The IPO was underwritten by Acumen Capital Finance Partners; Raymond James; Dlouhy Merchant Group; and First Associates Investments...
BioCentury | Feb 21, 2001
Financial News

Cytovax prices IPO

...250,005-share overallotment, was underwritten by Acumen Capital Finance Partners; Raymond James; Dlouhy Merchant Group; and First Associates Investments. BC...
Items per page:
1 - 5 of 5